110 related articles for article (PubMed ID: 14970907)
1. Purification and characterization of recombinant sTRAIL expressed in Escherichia coli.
Xia XX; Shen YL; Wei DZ
Acta Biochim Biophys Sin (Shanghai); 2004 Feb; 36(2):118-22. PubMed ID: 14970907
[TBL] [Abstract][Full Text] [Related]
2. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Lin Z; Lei H; Cao P
Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
[TBL] [Abstract][Full Text] [Related]
3. Refolding and purification of Apo2l/TRAIL produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli.
Shen YL; Xia XX; Zhang Y; Liu JW; Wei DZ; Yang SL
Biotechnol Lett; 2003 Dec; 25(24):2097-101. PubMed ID: 14969416
[TBL] [Abstract][Full Text] [Related]
4. High-level expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Wang D; Shi L
Appl Biochem Biotechnol; 2009 Apr; 157(1):1-9. PubMed ID: 19306078
[TBL] [Abstract][Full Text] [Related]
5. Cloning and purification of functionally active Fas ligand interfering protein (FIP) expressed in Escherichia coli.
Wisniewski P; Master A; Kaminska B
Acta Biochim Pol; 2008; 55(1):51-6. PubMed ID: 18204739
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification and crystallization of recombinant human TRAIL.
Cha SS; Shin HC; Choi KY; Oh BH
Acta Crystallogr D Biol Crystallogr; 1999 May; 55(Pt 5):1101-4. PubMed ID: 10216319
[TBL] [Abstract][Full Text] [Related]
7. [Cloning, expression and purification of human TNF-related apoptosis-inducing ligand in Escherichia coli].
Yao GH; Luan JF; Ye D; Lei QH; Zhu PY; Jin J; Hou YY
Wei Sheng Yan Jiu; 2006 Nov; 35(6):697-700. PubMed ID: 17290744
[TBL] [Abstract][Full Text] [Related]
8. Target cell-restricted apoptosis induction by 528scFv-TRAIL fusion protein specific for human EGFR and expressed in Escherichia coli.
Badran A; Asano R; Nakayama M; Watanabe Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kumagai I
Int J Oncol; 2010 May; 36(5):1229-34. PubMed ID: 20372797
[TBL] [Abstract][Full Text] [Related]
9. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin].
He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357
[TBL] [Abstract][Full Text] [Related]
10. Association of human tumor necrosis factor-related apoptosis inducing ligand with membrane upon acidification.
Nam GH; Choi KY
Eur J Biochem; 2002 Nov; 269(21):5280-7. PubMed ID: 12392561
[TBL] [Abstract][Full Text] [Related]
11. Facile purification of Escherichia coli expressed tag-free recombinant human tumor necrosis factor alpha from supernatant.
Zhang C; Liu Y; Zhao D; Li X; Yu R; Su Z
Protein Expr Purif; 2014 Mar; 95():195-203. PubMed ID: 24412132
[TBL] [Abstract][Full Text] [Related]
12. Fed-batch production of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in soluble form in Escherichia coli and its purification and characterization.
Li P; Gu Q; Wu X
Protein Expr Purif; 2016 Oct; 126():115-121. PubMed ID: 27335160
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative.
Wajant H; Moosmayer D; Wüest T; Bartke T; Gerlach E; Schönherr U; Peters N; Scheurich P; Pfizenmaier K
Oncogene; 2001 Jul; 20(30):4101-6. PubMed ID: 11494138
[TBL] [Abstract][Full Text] [Related]
14. High-level production of soluble tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in high-density cultivation of recombinant Escherichia coli using a combined feeding strategy.
Shen YL; Zhang Y; Sun AY; Xia XX; Wei DZ; Yang SL
Biotechnol Lett; 2004 Jun; 26(12):981-4. PubMed ID: 15269523
[TBL] [Abstract][Full Text] [Related]
15. Construction and expression of sTRAIL-melittin combining enhanced anticancer activity with antibacterial activity in Escherichia coli.
Liu H; Han Y; Fu H; Liu M; Wu J; Chen X; Zhang S; Chen Y
Appl Microbiol Biotechnol; 2013 Apr; 97(7):2877-84. PubMed ID: 23149754
[TBL] [Abstract][Full Text] [Related]
16. Optimization Studies on Prokaryotic Cell Expression of the Human Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL).
Hao L; Zhang ZG; Shi ZD; Pang K; Zhang JJ; Dong Y; Han CH
Cell Biochem Biophys; 2015 Nov; 73(2):275-279. PubMed ID: 25737132
[TBL] [Abstract][Full Text] [Related]
17. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
18. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS
J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019
[TBL] [Abstract][Full Text] [Related]
20. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli.
Upadhyay V; Singh A; Panda AK
Protein Expr Purif; 2016 Jan; 117():52-8. PubMed ID: 26390939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
